CTN012

N/A

Report date: 2024/12/05 13:33:45

Base Information

Drug NameCTN012
Drug Alias NameCTN012CTN-012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionFibroblast growth factor receptor 3 antagonists
TargetsFibroblast growth factor receptor 3
Therapy Area/IndicationsGallbladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentenaire Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCentenaire Biosciences Inc
Inactive CompaniesN/A
Active IndicationsGallbladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A